Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Evan R Myers

Biographic Data

ID4507263
NAMEEvan R Myers
GIVEN NAMESEvan R
FAMILY NAMEMyers
SIGNATUREMYERS E R
AFFILIATIONSDuke University
ORCID0000-0002-9053-9864
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
AUTHOR COUNT5
EDITOR COUNT0
FIRST PUBLICATION YEAR2001
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Ethno-Racial Differences in Age and Symptom Severity Among Pre-Menopausal Women Commencing Treatment for Benign Gynecological Conditions with a Levonorgestrel-Releasing Intrauterine Device

    Open Access•Matthew J Green, Kemi M Doll et al.•ARTICLE•Health Equity•2025

    Introduction: Levonorgestrel-releasing intrauterine devices (LNG-IUDs) can be effective treatments for benign gynecological conditions, but there may be ethno-racial differences in how patients receive treatment. Methods: Data were from a health care system in the U.S. South (April 2014-September 2019). We identified 783 female patients aged 18-44 years with an LNG-IUD for a benign gynecological condition (455 White, 208 Black, and 120 Hispanic p…

  • Estimated Monetary Value of Future Research Clarifying Uncertainties Around the Optimal Adult Hearing Screening Schedule

    Open Access•Ethan D Borre, Evan R Myers et al.•ARTICLE•JAMA Health Forum•2022

    In this economic evaluation of US adult hearing screening, large uncertainty around the optimal adult hearing screening schedule was identified. Future research on hearing screening has a high potential value so is likely justified

  • Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States

    Open Access•Masoom Priyadarshini, Vimalanand S Prabhu et al.•ARTICLE•Frontiers in Public Health•2021

    Objectives: To estimate years of potential life lost (YPLL) and present value of future lost productivity (PVFLP) associated with premature mortality due to HPV-attributable cancers, specifically those targeted by nonavalent HPV (9vHPV) vaccination, in the United States (US) before vaccine use. Methods: YPLL was estimated from the reported number of deaths in 2017 due to HPV-related cancers, the proportion attributable to 9vHPV-targeted types, an…

  • HPV vaccination uptake and administration from 2006 to 2016 in a commercially insured population of the United States

    Open Access•Vimalanand S Prabhu, Neha Bansal et al.•ARTICLE•BMC Public Health•2021

    Continued increase in uptake is needed to reach the ACS 2026 goals

  • Introduction and Methods

    Laura J Havrilesky, Jennifer M Gierisch et al.•ARTICLE•American Speech•2001

No prominent works on this page.

  • Introduction and Methods

    Laura J Havrilesky, Jennifer M Gierisch et al.•ARTICLE•American Speech•2001

  • Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States

    Open Access•Masoom Priyadarshini, Vimalanand S Prabhu et al.•ARTICLE•Frontiers in Public Health•2021

    Objectives: To estimate years of potential life lost (YPLL) and present value of future lost productivity (PVFLP) associated with premature mortality due to HPV-attributable cancers, specifically those targeted by nonavalent HPV (9vHPV) vaccination, in the United States (US) before vaccine use. Methods: YPLL was estimated from the reported number of deaths in 2017 due to HPV-related cancers, the proportion attributable to 9vHPV-targeted types, an…

  • HPV vaccination uptake and administration from 2006 to 2016 in a commercially insured population of the United States

    Open Access•Vimalanand S Prabhu, Neha Bansal et al.•ARTICLE•BMC Public Health•2021

    Continued increase in uptake is needed to reach the ACS 2026 goals

  • Estimated Monetary Value of Future Research Clarifying Uncertainties Around the Optimal Adult Hearing Screening Schedule

    Open Access•Ethan D Borre, Evan R Myers et al.•ARTICLE•JAMA Health Forum•2022

    In this economic evaluation of US adult hearing screening, large uncertainty around the optimal adult hearing screening schedule was identified. Future research on hearing screening has a high potential value so is likely justified

  • Ethno-Racial Differences in Age and Symptom Severity Among Pre-Menopausal Women Commencing Treatment for Benign Gynecological Conditions with a Levonorgestrel-Releasing Intrauterine Device

    Open Access•Matthew J Green, Kemi M Doll et al.•ARTICLE•Health Equity•2025

    Introduction: Levonorgestrel-releasing intrauterine devices (LNG-IUDs) can be effective treatments for benign gynecological conditions, but there may be ethno-racial differences in how patients receive treatment. Methods: Data were from a health care system in the U.S. South (April 2014-September 2019). We identified 783 female patients aged 18-44 years with an LNG-IUD for a benign gynecological condition (455 White, 208 Black, and 120 Hispanic p…

Medicine (4 works) · Demography (3 works) · Population (3 works) · Demography (2 works) · Environmental health (2 works) · Internal Medicine (2 works) · Pediatrics (2 works) · Actuarial science (1 work) · Attributable risk (1 work) · Audiology (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae